EN
CN
News
Home > News > News  > The Special Report of the "Ingenuity" Program on Reinovax Biologics -“Ingenious Cultivation，Innovative Vaccine” " Was Officially Broadcast on CCTV!
The Special Report of the "Ingenuity" Program on Reinovax Biologics -“Ingenious Cultivation，Innovative Vaccine” " Was Officially Broadcast on CCTV!
2024-10-23News

Fulfilling the Mission, Establishing Quality, [Reinovax Biologics] Keeps Original Aspiration and Persistent Ingenuity.

 

Last:Reinovax successfully completed a Phase II trial in adults for its novel 24-valent pneumococcal conjugate vaccine
Next:Reinovax Biologics Initiated Phase I Clinical Trial of 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine in Infants and Toddlers
Back
News Center
News Recommendation
Go Innovative For Better Health
About Us
About Reinovax
An Integrated System
History
Company Culture
Exhibition
Technology
R&D Platform
An Integrated System
Product
PCV24
Pipeline
Partnership
Partnership
News
News
Careers
ESG
Talent Concept
Career Planning
Employee Growth
Open Recruitment
Contact Us
Contact Reinovax
Shanghai Reinovax Biologics Co., Ltd.
Tel.: 021-50999002
E-mail: info@reinovax.com
Address: 5th floor, Building 1,367 Shengrong Road
Pudong New District, Shanghai, China
◎Shanghai Reinovax Biologics Co., Ltd. Copyright.沪ICP备17050675号-2
Design By Paiky Network